The Biosimilars Act established two distinct categories of generic biologics; biosimilars michael kors cheap and "interchangeable" biologic products. Only the "interchangeable" biologic products are required to have new clinical trials to be considered legitimate as a suitable replacement. These "interchangeable" products will account for most of the new biosimilar drugs released over the next decade..
http://www.rewebservice.es/?q=node/20265
http://www.sinoprofessionals.org/node/19905
http://somdmda.org/6_httpwwwskipjack_nathanorgsalingphp_zxc_20